Volume 62, Issue 5, Pages (November 2002)

Slides:



Advertisements
Similar presentations
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Isolated Quadriceps Training Increases Maximal Exercise.
Advertisements

Kamyar Kalantar-Zadeh  Kidney International 
Volume 66, Issue 6, Pages (December 2004)
Volume 54, Issue 2, Pages (August 1998)
Volume 70, Issue 3, Pages (August 2006)
End-stage renal disease in developing countries
Volume 83, Issue 3, Pages (March 2013)
Volume 58, Issue 4, Pages (October 2000)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Determinants of phosphorus mobilization during hemodialysis
AJKD Atlas of Renal Pathology: Chronic Antibody-Mediated Rejection
Volume 91, Issue 3, Pages (March 2017)
Volume 61, Issue 5, Pages (May 2002)
Glomerular disease related to anti-VEGF therapy
Section 5: Dialysis Interventions for Treatment of AKI
Overcoming barriers that inhibit proper treatment of anemia
Kamyar Kalantar-Zadeh  Kidney International 
G. Murcutt, J. Edwards, J. Boakye, A. Davenport  Kidney International 
Volume 71, Issue 2, Pages (January 2007)
Volume 75, Issue 12, Pages (June 2009)
Comorbidity and confounding in end-stage renal disease
Enlarged nephrons and severe nondiabetic nephropathy in hepatocyte nuclear factor-1β (HNF-1β) mutation carriers  Jørn V. Sagen, Leif Bostad, Pål R. Njølstad,
Volume 54, Issue 2, Pages (August 1998)
Volume 70, Issue 11, Pages (December 2006)
Joseph W. Eschbach, John W. Adamson  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
Volume 60, Issue 3, Pages (September 2001)
Acute myocardial infarction in patients with end-stage renal disease
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Blood pressure targets in hemodialysis patients
Insulin Transport within Skeletal Muscle Transverse Tubule Networks
Volume 66, Issue 5, Pages (November 2004)
The promise of biomarkers for personalized renal cancer care
Expression of connective tissue growth factor in human renal fibrosis
Volume 63, Issue 2, Pages (February 2003)
Volume 70, Issue 9, Pages (November 2006)
An unusual cause of acute renal failure
Volume 76, Issue 6, Pages (September 2009)
The Case | Idiopathic hypocomplementemic interstitial nephritis
Volume 57, Issue 6, Pages (June 2000)
Volume 62, Issue 5, Pages (November 2002)
Volume 65, Issue 4, Pages (April 2004)
Increased susceptibility to erythrocyte C5b-9 deposition and complement-mediated lysis in chronic renal failure  Jonathan Himmelfarb, Ellen Mcmonagle,
Cardiovascular disease in pediatric chronic dialysis patients
Volume 87, Issue 3, Pages (March 2015)
What can be learned using microarrays?
Juan Camilo Duque, Roberto I. Vazquez-Padron  Kidney International 
Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen 
Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease  Shen Xiao, Laszlo Wagner, Rebecca J. Schmidt,
Antiglomerular basement membrane disease with normal renal function
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Volume 64, Issue 2, Pages (August 2003)
Racial differences in survival of patients on dialysis
Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass 
D. Fuster, A. Monegal, J.-V. Torregrosa  Kidney International 
The Danish Renal Biopsy Register
Volume 80, Issue 10, Pages (November 2011)
Volume 70, Issue 2, Pages (July 2006)
Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction  Malcolm F. Hand, William G. Haynes, David J.
The hypothesis that abnormal BH4 metabolism impairs kidney function
Is complement a target for therapy in renal disease?
Volume 68, Issue 1, Pages (July 2005)
Volume 70, Issue 10, Pages (November 2006)
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Prediction in idiopathic membranous nephropathy
Volume 56, Issue 6, Pages (December 1999)
Eric N Haugen, Anthony J Croatt, Karl A. Nath  Kidney International 
Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund 
Volume 63, Issue 1, Pages (January 2003)
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Volume 62, Issue 5, Pages 1901-1913 (November 2002) Uremic myopathy  Josep M. Campistol  Kidney International  Volume 62, Issue 5, Pages 1901-1913 (November 2002) DOI: 10.1046/j.1523-1755.2002.00614.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 (A) Relationship between leg quadriceps maximum O2 uptate (peak VO2, L · min-1) and work rate, expressed in grams, in uremic patients and normal subjects breathing three different inspired O2 concentrations: hypoxia, normoxia, and hyperoxia. Patients with chronic renal failure showed a strong linear relationship between peak VO2 and work rate, suggesting an oxygen supply dependency and indicating a limitation on O2 transport from the capillary to the mitochondria. Symbols are: (▪) dialysis patients; (▵) normal subjects. (Reprinted with permission from J Clin Invest41). (B) 31P-MRS examination during exercise, comparing cellular bioenergetics between uremic patients (▪; breathing 100% O2) and the control group (▵; breathing 21% O2). No significant differences could be demonstrated in cellular bioenergetics between the two groups. (Reprinted with permission from J Clin Invest50). (C) Plot between the leg quadriceps peak O2 uptake (peak VO2 leg, L · min-1) and oxymyoglobin saturation in uremic patients and normal subjects breathing three different inspired O2 concentrations. Oxymyoglobin saturation at a given FiO2 was lower in the uremic patients (▪) than in the controls (▵). The lower the FiO2, the lower the oxymyoglobin saturation within each group. The results obtained in the two groups fit the same curve. (Reprinted with permission from Am J Physiol42.) Kidney International 2002 62, 1901-1913DOI: (10.1046/j.1523-1755.2002.00614.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 (A) Muscle biopsy (vastus lateralis) of a patient with end-stage renal failure on dialysis therapy. Transverse section stained simultaneously with NADH tetrazolium reductase and Ulex europeus. Dark fibers correspond to type-I fibers, pale fibers to type-II fibers, and black small points between them are capillaries (magnification ×100). (B) Electron microscopy of a muscle biopsy from a dialysis patient. The capillary surface, diameter, and capillary basement membrane were strictly normal, with no significant differences from the control group (magnification ×5000). Kidney International 2002 62, 1901-1913DOI: (10.1046/j.1523-1755.2002.00614.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Northern blots for vascular endothelial growth factor (VEGF) in skeletal muscle biopsies from uremic patients and control subjects before (R) and after (E) exercise. VEGF-mRNA abundance is greatly increased after exercise in both groups. Reprinted with permission from Am J Physiol38. Kidney International 2002 62, 1901-1913DOI: (10.1046/j.1523-1755.2002.00614.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Densitometric data from the Northern blots, showing the large increase in VEGF-mRNA with a single bout of exercise in uremic patients and control subjects. The increase was eightfold in dialysis patients versus sixfold in the control group (P, not significant). Symbols are: () rest; (▪) exercise. Reprinted with permission from Am J Physiol38. Kidney International 2002 62, 1901-1913DOI: (10.1046/j.1523-1755.2002.00614.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Kidney International 2002 62, 1901-1913DOI: (10. 1046/j. 1523-1755 Kidney International 2002 62, 1901-1913DOI: (10.1046/j.1523-1755.2002.00614.x) Copyright © 2002 International Society of Nephrology Terms and Conditions